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INTRODUCTION Medial temporal lobe epilepsy (MTLE) is the most common
type of symptomatic epilepsy. The intrahippocampal kainic acid (KA) model is a model
of MTLE in rats with a status epilepticus induced by KA injection as the precipitating
insult. As functional and structural changes occur during epileptogenesis, multimodal
imaging techniques such as PET-MRI can provide new insights in this process. We have
investigated the metabolic and structural changes in the KA model using sequential
dynamic PET and 7T MRI.
MATERIALS AND METHODS A cannula was stereotactically placed in the
right intermediate hippocampus (AP=-5.6 mm, ML=+4.5 mm, DV=-5.5 mm relative
to bregma) of 13 Sprague Dawley rats (male, 300g). After 1 week, PET-CT and MRI
imaging was performed on a GMI Triumph II micro-PET/SPECT/CT and a Bruker
Pharmascan 7T respectively. Imaging was performed on three consecutive days. On
the first day a pre-injection T2-weighted (T2w) MRI was acquired. Then a CT scan
was performed directly followed by a 180 min dynamic PET acquisition with continuous
infusion of 18F-FDG. First a 300 µCi bolus was administered followed by continuous
adjustment of the infusion rate to maintain a constant radioactivity level inside the
animal. After 90 min KA (n=10) or saline (n=3) was injected (0.1 µg/0.1 µl; 0.1 µl/min).
Subsequently, a T2w MRI was acquired at 2h, 24h and 48h after injection. PET images
were reconstructed in 10 min frames using ML-EM (50 iterations). Volumes of interest
were drawn on the right and left hippocampus and the right-to-left ratio uptake ratio
was calculated. The average of this ratio (= Ravg) within both groups was calculated
in each frame. Student’s t-test was used to determine significant differences (p <0.05).
T2w MR images were coregistered with the CT using normalized mutual information.
RESULTS Before injection, Ravg was between 96% and 104% in both groups. After
injection Ravg progressively increased in the KA group (140±20 % at 75 min). In the
saline group no increase was observed (104±4 % at 75 min). The difference between
both groups was significant at 35 min or more after injection. On T2w MR images a
small zone of oedema was visible around the injection site in the KA group 2h post-
KA, which increased after 24h and 48h. In some rats oedema was also observed in the
ipsilateral and contralateral entorhinal cortex. No increased FDG uptake was seen in
these regions. In the saline group no significant changes were observed on T2w MR
images.
CONCLUSION We have used PET-MRI to visualize metabolic and structural
changes in the acute phase of the KA model. PET imaging showed a significant in-
crease in glucose metabolism immediately after KA injection. Structural changes were
limited on T2w MR images directly after injection, but progressively increased over 48h.
This may indicate that metabolic hyperactivation in the acute phase induces structural
changes that occur during the post-injection period. When available, simultaneous PET-
MRI could be used in this study to collect extra information during the acute phase,
such as fMRI pre- and post-injection.
